⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
Intraocular Lens Market Poised for Strong Growth as Rising Cataract Procedures and Premium Vision Correction Demand Accelerate: Verified Market Research®
prnewswire.com
ALC
BHC
JNJ
SGA
ABT
Stella Mental Health Expands Boston-Area Services with New Newton Clinic as Chief Psychiatric Officer Dr. Brian Boyle Selected as 2026 National SPRAVATO® Bureau Speaker
prnewswire.com
JNJ
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
globenewswire.com
SUPN
MGTX
JNJ
ARWR
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
prnewswire.com
JNJ
CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
prnewswire.com
BMY
GILD
JNJ
CRSP
ALLO
CART
Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer
prnewswire.com
JNJ
PFE
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
prnewswire.com
JNJ
MEXC and Ondo Finance Expand Tokenized Stock Partnership with 17 New Spot Pairs and Zero-Fee Trading
globenewswire.com
MSFT
JNJ
JPM
BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight
prnewswire.com
ABBV
AMGN
AZN
BMY
GILD
JNJ
LLY
MRK
NVS
PFE
SNY
TMO